114 results found.
SeaSpine Reports Preliminary 2Q17 Revenue
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16.
Full Commercial Launch for SeaSpine's Mariner Posterior Fixation
SeaSpine commenced full launch of the Mariner® pedicle-based system for posterior spinal fixation
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
SeaSpine Posts 1Q17 Revenue
SeaSpine announced 1Q17 revenue of US $31.9MM, +1.6% vs. 1Q16. (U.S. $28.6MM, +0.2%; ex-U.S. $3.3MM, +15.6%)
Orthopaedic Industry Revenue Reaches $48.1 Billion
By Carolyn LaWell Orthopaedic industry revenue reached $48.1 billion worldwide in 2016 and grew at 3.2%, ~$1.5 billion over 2015, according to our estimates published in the
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
SeaSpine Reports 4Q16 and 2016 Revenue
SeaSpine announced 2016 revenue of US $128.9MM, -3.2% vs. 2015, with 4Q16 revenue of $32.5MM, -6.5% vs. 4...
Full Launch of SeaSpine's Vu aPOD Prime NanoMetalene System
SeaSpine commenced full commercial launch of the Vu aPOD™ Prime NanoMetalene System for 
Year in Review: First 510(k)s in 2016
Every month, we examine FDA’s 510(k) database to learn about products heading to market and the companies that intend to bring them there. Here, we’ve captured highlights from that work over the last year.  The following 18 companies received their first FDA 510(k) in 2016...
Globus Medical Preliminary 2016/4Q16 Revenue
Globus Medical announced preliminary unaudited 2016 sales of ~US $564.0MM, with 4Q16 sales of ~$151.6MM
SeaSpine Announces Preliminary 4Q16, Full Year 2016 Revenue
SeaSpine announced preliminary unaudited 2016 sales in the range of ~US $128.8MM and $129.0MM, and 4Q16 sales
Limited U.S. Launch for Carevature's Spinal Decompression System
Carevature commenced limited U.S. launch of Dreal™ products for spinal decompression.
Recap: NASS Week 2016
In 2015, it was interbody cages, sacroiliac joints, artificial discs and robotics. This year, e...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
SeaSpine Posts 3Q16 Revenue
SeaSpine announced 3Q16 revenue of US $31.8MM, -2.7% vs. 3Q15.
SeaSpine Receives FDA 510(k) Clearance for Mariner Posterior Fixation
SeaSpine received FDA 510(k) clearance to market the Mariner™ Posterior Fixation pedicle ...
SeaSpine Receives FDA 510(k) Clearance for Shoreline ACS System
SeaSpine received FDA 510(k) clearance to market the Shoreline™ ACS Anterior Cervical Standalone system.
M&A Close-up: 2016 Transactions Year to Date
ORTHOWORLD’s M&A Activity database has logged 39 transactions year to date for 2016, already ahead of 2015’s whole-year total of 36. A variety of company types are represented (OEM, Supplier, Distributor, Private Equity), and the values range from $10 million to $1 billion. ...
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Spine Company 510(k)s from 1H16: Newcomers Aren’t All at NASS
Spine remains an active arena for market entrants, but attending the annual NASS meeting isn’t the only way to keep an eye on newcomers to the space. Every month, ORTHOWORLD examines updates to FDA’s orthopaedic-related 510(k) database and highlights those clearances deemed ...
SeaSpine to Acquire NLT Spine, Expandable Interbody Platform Technologies
SeaSpine entered into a definitive agreement to acquire NLT Spine, developer of minimally invasive surg...
SeaSpine Reports 2Q16 Revenue
SeaSpine announced 2Q16 revenue of US $33.2MM, -0.8% vs. 2Q15. Growth is as reported.
SeaSpine Introduces Hollywood VI NanoMetalene Interbody Device
SeaSpine commenced full commercial launch of the Hollywood™ VI (variable insertion)
SeaSpine Reports 1Q16 Revenue
SeaSpine announced 1Q16 revenue of US $31.4MM, -2.8% vs. 1Q15. (Spine $14.7MM, -9.5%; Orthobiologics $16.7MM, +3.9%
SeaSpine Reports 4Q15/2015 Revenue
SeaSpine announced 4Q15 revenue of US $34.7MM, -1% from 4Q14, and 2015 revenue of $133.2MM, -4% vs. 2014. (2...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group